Cargando…
Can omalizumab be used effectively to treat severe conjunctivitis in children with asthma? A case example and review of the literature
A 14-year-old girl with poorly controlled asthma attended the difficult-to-treat asthma clinic for review. Although she has eosinophilia and significantly raised immunoglobulin E levels, she is not currently a candidate for omalizumab (Xolair). She also suffers from chronic urticaria, eosinophilic e...
Autores principales: | Doherty, Stephen, Mulholland, Melissa, Shields, Michael, McCrossan, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290994/ https://www.ncbi.nlm.nih.gov/pubmed/34316438 http://dx.doi.org/10.5409/wjcp.v10.i4.48 |
Ejemplares similares
-
Bacterial conjunctivitis
por: Hutnik, Cindy, et al.
Publicado: (2010) -
How we teach children with asthma to use their inhaler: a scoping review protocol
por: McCrossan, Patrick, et al.
Publicado: (2020) -
How we teach children with asthma to use their inhaler: a scoping review
por: McCrossan, Patrick, et al.
Publicado: (2022) -
Severe asthma and the omalizumab option
por: Miller, Christopher WT, et al.
Publicado: (2008) -
The use of remote video directly observed therapy to improve both inhaler technique and adherence to asthma medications
por: McCrossan, Paddy, et al.
Publicado: (2022)